Implementing a Methadone Delivery System in New York City in Response to COVID-19.
Am J Public Health
; 111(12): 2115-2117, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1561322
ABSTRACT
Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111(12)2115-2117. https//doi.org/10.2105/AJPH.2021.306523).
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Communicable Disease Control
/
Opiate Substitution Treatment
/
COVID-19
/
Methadone
/
Opioid-Related Disorders
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
North America
Language:
English
Journal:
Am J Public Health
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS